Correlation Between NextCure and Inhibrx
Can any of the company-specific risk be diversified away by investing in both NextCure and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Inhibrx, you can compare the effects of market volatilities on NextCure and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Inhibrx.
Diversification Opportunities for NextCure and Inhibrx
Very weak diversification
The 3 months correlation between NextCure and Inhibrx is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of NextCure i.e., NextCure and Inhibrx go up and down completely randomly.
Pair Corralation between NextCure and Inhibrx
Given the investment horizon of 90 days NextCure is expected to under-perform the Inhibrx. In addition to that, NextCure is 1.58 times more volatile than Inhibrx. It trades about -0.26 of its total potential returns per unit of risk. Inhibrx is currently generating about -0.02 per unit of volatility. If you would invest 1,486 in Inhibrx on September 24, 2024 and sell it today you would lose (26.00) from holding Inhibrx or give up 1.75% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NextCure vs. Inhibrx
Performance |
Timeline |
NextCure |
Inhibrx |
NextCure and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NextCure and Inhibrx
The main advantage of trading using opposite NextCure and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Inhibrx vs. Fate Therapeutics | Inhibrx vs. Sana Biotechnology | Inhibrx vs. Caribou Biosciences | Inhibrx vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |